Immunobiological preparations

Dittmann, 1990, Adverse events following immunization Centers for Disease Control, 1986 Dittmann, 1990, Monitoring of side effects of adverse events following immunization Fenichel, 1989, Adverse events following immunization: assessing probability of causation, Pediatr. Neurol., 5, 287, 10.1016/0887-8994(89)90019-2 Floyd, 1989, Survey to establish the incidence of minor side effects in infants following protective immunization, J. R. Coll. Gen. Pract., 39, 359 Health Council of The Netherlands, 1990, Adverse Reactions to Vaccines in the National Immunization Programme in 1988 Morrison, 1988, Vaccine adverse reaction in young children in Ontario, Can. J. Publ. Health, 79, 459 Reynes, 1989, BCG adenitis 30 years after immunization in a patient with AIDS, J. Infect. Dis., 160, 727, 10.1093/infdis/160.4.727 Berkley, 1990, Immunization and fear of AIDS, Lancet, 1, 47, 10.1016/0140-6736(90)90171-Z WHO/UNICEF, 1989, Joint WHO/UNICEF statement on early immunization for HIV-infected children, Wkly Epidemiol. Rec., 64, 48 Milstien, 1990, Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety, Bull. WHO, 68, 93 WHO, 1989, BCG-associated lymphadenitis in infants, Wkly Epidemiol. Rec., 64, 231 Gonzalez, 1989, Clinical presentation of BCG infections in patients with immunodeficiency syndromes, Pediatr. Infect. Dis. J., 8, 201 Tardieu, 1988, Tuberculous meningitis due to BCG in two previously healthy children, Lancet, 1, 440, 10.1016/S0140-6736(88)91233-0 Morrison, 1988, Meningitis after BCG vaccination, Lancet, 1, 654, 10.1016/S0140-6736(88)91460-2 Lester, 1988, BCG endophthalmitis, Retina, 8, 182, 10.1097/00006982-198808030-00006 De Santi, 1989, Descrizione di un caso di osteite da BCG (BCG osteitis: a case report), Riv. Ital. Pediatr., 15, 398 Zahaf, 1989, Lupus tuberculeux induit par le BCG, Sem. Hôp. Paris, 65, 111 Dae Won, 1989, A case of lupus vulgaris following BCG vaccination, Korean J. Dermatol., 27, 217 Raos, 1988, Velikij granulom, rijetka lokalna komplikacija BCG vakcinacije (Comprehensive BCG granuloma—a rare local complication caused by BCG vaccination), Med. Jad., 18, 1 Burdeny, 1989, Calcification of axillary lymph nodes following BCG vaccination, J. Can. Assoc. Radiol., 40, 92 Marik, 1988, Osteitis caused by BCG vaccination, J. Pediatr. Orthop., 8, 333, 10.1097/01241398-198805000-00015 Beisland, 1989, Intravesikal BCG-vaksine ved blaerecancer (Intravesical immunotherapy for bladder cancer), Tidsskr. Nor. Laegeforen., 109, 1891 Martínez, 1989, Nuestra experiencia en el tratamiento del cáncer superficial de vijega con BCG, Arch. Esp. Urol., 42, 325 Steg, 1989, Systemic BCG infection, ‘BCGitis’, in patients treated by intravesical BCG therapy for bladder cancer, Eur. Urol., 16, 161, 10.1159/000471561 Guinan, 1989, Intravesical BCG and second primary malignancies, Urology, 33, 380, 10.1016/0090-4295(89)90029-0 Khanna, 1989, Intravesical BCG and second primary malignancies, Urology, 34, 113, 10.1016/0090-4295(89)90178-7 Ran, 1989, Persistent acid-fast bacilli following intravesical BCG, J. Urol., 141, 1197, 10.1016/S0022-5347(17)41212-2 Bornet, 1989, Tuberculous aneurysm of the femoral artery: a complication of BCG vaccine immunotherapy—a case report, J. Vasc. Surg., 10, 688 Hughes, 1989, Arthritis associated with adjuvent mycobacterial treatment of the bladder, Ann. Rheum. Dis., 48, 432, 10.1136/ard.48.5.432 Yoshimura, 1988, Severely contracted bladder following intravesical BCG therapy—a case report, Jpn. J. Urol., 79, 1848, 10.5980/jpnjurol1928.79.11_1848 Kondratowicz, 1989, BCG Pyelonephritis following intra-vesical BCG, Br. J. Urol., 64, 649, 10.1111/j.1464-410X.1989.tb05329.x Shea, 1989, Granulomatous eruptíon after BCG vaccine immunotherapy for malignant melanoma, J. Am. Acad. Dermatol., 21, 1119, 10.1016/S0190-9622(89)70310-8 Agbayani, 1989, BCG immunotherapy for allergic asthma: a preliminary report, Phil. J. Intern. Med., 27, 261 Manzillo, 1988, Study for the evaluation of the tolerability (local and general) of an anti-cholera vaccine, made by Mérieux Institute, Rass. Int. Clin. Ter., 68, 894 Mark, 1989, Immunity and immunization of children against diphtheria in Sweden, Eur. J. Microbiol. Infect. Dis., 8, 214, 10.1007/BF01965263 Björkholm, 1989, Immune status and booster effects of low dose of diphtheria toxoid in Swedish medical personnel, Scand. J. Infect. Dis., 21, 429, 10.3109/00365548909167448 Griffith, 1988, Erythema multiforme following diphtheria and tetanus toxoid vaccination, J. Acad. Dermatol., 19, 758, 10.1016/S0190-9622(88)80355-4 Peltola, 1989, Invasive Haemophilus influenzae type b diseases in continental Europe WHO Expert Committee on Biological Standardization, 1990 Just, 1990, Zur Impfprophylaxe von Haemophilus-influenzae-B-Infektionen, Kinderarzt, 21, 42 Just, 1989, Haemophilus type b PRP-D conjugate vaccine trial in 3-month-old children in Switzerland Olafson, 1989, The launch of an infant Haemophilus influenzae type b immunization programme in Iceland Van Exan, 1989, Epidemiology of Haemophilus influenzae type b disease in Canada and cost—benefit analysis for evaluating Haemophilus vaccination programmes Reinert, 1989, Tolérance et immunogénicité du vaccin polyosidique capsulaire anti-Haemophilus influenzae type b, Ann. Pédiatr., 36, 20 Tudor-Williams, 1989, Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom, Arch. Dis. Child., 64, 520, 10.1136/adc.64.4.520 Isenberg, 1990, Haemophilus influenzae Typ B-Infektions-krankheiten Jakacki, 1990, Haemophilus—diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease, Ann. Intern. Med., 112, 143, 10.7326/0003-4819-112-2-143 Weinberg, 1988, Polysaccharide—protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease, J. Pediatr., 113, 621, 10.1016/S0022-3476(88)80369-X D'Cruz, 1989, Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine, J. Pediatr., 115, 743, 10.1016/S0022-3476(89)80653-5 Tanner A (1989) Personal communication. Marchant, 1989, Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide—diphtheria conjugate vaccine, Pediatr. Infect. Dis. J., 8, 508, 10.1097/00006454-198908000-00007 Yogev, 1990, Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety of various doses, Pediatrics, Suppl., 691 Ahonkhai, 1990, Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (Pedvax HIB): clinical evaluation, Pediatrics, Suppl., 676, 10.1542/peds.85.4.676 Hood, 1989, Meningococcal vaccine—do some children experience side effects?, NZ Med. J., 102, 65 Novelli, 1989, Febrile seizures after immunization with meningococcal A+C vaccine, Pediatr. Infect. Dis. J., 8, 250 Griffith, 1989, Permanent brain damage and pertussis vaccination: is the end of the saga in sight?, Vaccine, 7, 199, 10.1016/0264-410X(89)90229-6 Miller, 1990, Pertussis vaccine and severe acute neurological illnesses. Response to a recent review by member of the NCES team, Vaccine, 7, 487, 10.1016/0264-410X(89)90268-5 Griffith, 1989, Pertussis vaccine and permanent brain damage, Vaccine, 7, 489, 10.1016/0264-410X(89)90269-7 Griffin, 1990, Risk of seizures and encephalopathy after immunization with DTP vaccine, J. Am. Med. Assoc., 263, 1641, 10.1001/jama.1990.03440120063038 Walker, 1988, Neurological events following DTP immunization, Pediatrics, 81, 345, 10.1542/peds.81.3.345 Baraff, 1988, Infants and children with convulsions and hypotonic-hyporesponsive episodes following DTP, Pediatrics, 81, 789 Long, 1990, Longitudinal study of adverse reactions following DTP vaccine in infancy, Pediatrics, 85, 294, 10.1542/peds.85.3.294 Plotkin, 1989, Pertussis, Vaccine, 7, 195, 10.1016/0264-410X(89)90227-2 Cherry, 1990, ‘Pertussis vaccine encephalopathy’: It is time to recognize it as the myth that it is, J. Am. Med. Assoc., 263, 1679, 10.1001/jama.1990.03440120101046 Goldman, 1988, Pertussis vaccine: Is the controversy nearly over?, Can. Med. Assoc. J., 139, 1062 Livengood, 1989, Family history of convulsions and use of pertussis vaccine, J. pediatr., 115, 527, 10.1016/S0022-3476(89)80275-6 Gross, 1989, Bulging fontanelle after immunization with DTP and DT vaccine, J. Pediatr., 114, 423, 10.1016/S0022-3476(89)80562-1 Bouvier-Colle, 1989, Sudden infant death and immunization: an extensive epidemiological approach to the problem in France—Winter 1986, Int. J. Epidemiol., 18, 121, 10.1093/ije/18.1.121 Baraff, 1989, Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain, Pediatr. Infect. Dis. J., 8, 502, 10.1097/00006454-198908000-00006 Scheifele, 1989, Local adverse reactions to DTP vaccine, adsorbed, in Surrey, BC, Can. Med. Assoc. J., 141, 312 Ipp, 1989, Adverse reactions to DTP/IPV vaccination at 18 months of age: effect of injection site and needle length, Pediatrics, 83, 679, 10.1542/peds.83.5.679 Bytchenko, 1989, Expert examination of the immunogenic activity and toxicity of the pertussis component of adsorbed and non-adsorbed DTP vaccines, J. Hyg. Epidemiol. Microbiol. Immunol., 33, 453 Shields, 1988, Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study, J. Pediatr., 113, 801, 10.1016/S0022-3476(88)80004-0 Hederstedt, 1989, Adverse reactions and antibody response to an acellular pertussis toxoid vaccine in adult volunteers, Vaccine, 7, 349, 10.1016/0264-410X(89)90200-4 Blennow, 1989, Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants, Pediatrics, 84, 62 Edwards, 1989, Evaluation of new highly purified pertussis vaccine in infants and children, J. Infect. Dis., 160, 832, 10.1093/infdis/160.5.832 Immunization, 1990, Recommendations on typhoid immunization, Morbid. Mortal. Wkly Rep., 39, 1 Keane, 1989, Reiter's syndrome precipitated by a typhoid vaccination, Br. J. Rheumatol., 27, 496, 10.1093/rheumatology/27.6.496-a Beishuizen, 1988, Typhoidfever-like syndrome after Ty21a live oral vaccine, Lancet, 1, 855, 10.1016/S0140-6736(88)92823-1 Biron, 1988, Myasthenia gravis after general anaesthesia and hepatitis B vaccine, Arch. Intern. Med., 148, 2685, 10.1001/archinte.1988.00380120123025 Murata, 1989, Prevention of vertical transmission of hepatitis B virus by yeast recombinant hepatitis vaccine, Acta Paediatr. Jpn., 31, 180, 10.1111/j.1442-200X.1989.tb01287.x Lancaster, 1989, Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis vaccine, Am. J. Infect. Control, 17, 126, 10.1016/0196-6553(89)90198-3 Morris, 1989, Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age, Epidemiol. Infect., 103, 387, 10.1017/S0950268800030740 Tuohy, 1989, Guillain Barré syndrome following immunization with synthetic hepatitis B vaccine, NZ Med. J., 102, 114 Fauci, 1989, NIH conference. Development and evaluation of a vacine for human immunodeficiency virus infection, Ann. Intern. Med., 110, 373, 10.7326/0003-4819-110-5-373 Immunization, 1989, Recommendations on prevention and control of influenza, Morbid. Mortal. Wkly Rep., 38, 297 Scheifele, 1990, Evaluation of adverse events after influenza vaccination in hospital personnel, Can. Med. Assoc. J., 142, 127 Margolis, 1990, Frequency of adverse reactions after influenza vaccination, Am. J. Med., 88, 27, 10.1016/0002-9343(90)90123-U Gerth, 1989, Grippeschutzimpfung, Dtsch. Med. Wochenschr., 114, 180 Faguet, 1981, The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes, J. Infect. Dis., 143, 252, 10.1093/infdis/143.2.252 Schmidt, 1982, E-Rosette forming cells and humoral antibody titers in human after vaccination with three different influenza vaccines, Acta Virol., 27, 466 Okuno, 1989, Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan, Int. J. Epidemiol., 18, 684, 10.1093/ije/18.3.684 Gerike E, Dittmann S (1990) personal communication. Markowitz, 1990, Immunization of 6-months-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines, N. Engl. J. Med., 322, 580, 10.1056/NEJM199003013220903 Whittle, 1988, Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects, Lancet, 2, 811, 10.1016/S0140-6736(88)92781-X WHO, 1989, Report of the Expanded Programme on immunization Friedländerova, 1986, Psoriasis incidence research in young generation relating to vaccination against measles, Acta Univ. Carol. Med., 32, 221 Kemp, 1990, Measles immunization in children with clinical reactions to egg protein, Am. J. Dis. Control., 144, 33 Stiehm, 1990, Skin testing prior to measles vaccination for egg-sensitive patients, Am. J. Dis. Control., 144, 32 Olivares, 1989, Anemia of a mild viral infection: the measles vaccine as a model, Pediatrics, 84, 851, 10.1542/peds.84.5.851 Greenberg, 1988, Safe administration of measles-mumps-rubella vaccine in egg-allergic children, J. Pediatr., 113, 504, 10.1016/S0022-3476(88)80639-5 Ljungman, 1989, Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine, J. Infect. Dis., 159, 610, 10.1093/infdis/159.4.610 Miller, 1989, Surveillance of symptoms following MMR vaccine in children, Practitioner, 233, 69 Glöckler, 1987, Erfahrungsbericht über einen MMR- bzw. Masern-Mumps-Impfstoff, Jatros Pädiatr., 3, 1 von Mühlendahl, 1989, Side Effects and complications of measles-mumps vaccination, Monatsschr. Kinderheilkd., 137, 440 Beck, 1989, Mumps vaccine L-Zagreb prepared in chick fibroblasts I. Production and field trials, J. Biol. Stand., 17, 85, 10.1016/0092-1157(89)90031-0 Quast, 1979, Vaccine-induced mumps-like diseases, Dev. Biol. Stand., 43, 269 Mc Donald, 1989, Clinical and epidemiological features of mumps meningoencephalitis and possible vaccine-related disease, Pediatr. Infect. Dis. J., 8, 751, 10.1097/00006454-198911000-00004 Hocking, 1988, Mumps meningitis, possibly vaccine-related (Ontario), Can. Dis. Wkly. Rep., 14, 209 Gray, 1989, Mumps meningitis following MMR immunization, Lancet, 2, 98, 10.1016/S0140-6736(89)90332-2 Begg, 1989, Measles, mumps, and rubella vaccination and encephalitis, Br. Med. J., 299, 978, 10.1136/bmj.299.6705.978-b 1989, Mumps meningitis and MMR vaccination, Lancet, 2, 1015 1988, Mumps meningitis: possible association with MMR vaccine, PHLS Commun. Dis. Rep., 89/23 Murray, 1989, Mumps meningitis after MMR vaccination, Lancet, 2, 677, 10.1016/S0140-6736(89)90918-5 von Mühlendahl, 1989, Mumps meningitis following MMR immunization, Lancet, 2, 394, 10.1016/S0140-6736(89)90576-X Ehrengut, 1989, Complications after preventive mumps vaccination in West Germany, Monatsschr. Kinderheilkd., 137, 398 Cizman, 1989, Aseptic meningitis after vaccination against measles and mumps, Pediatr. Infect. Dis. J., 8, 302 Nalin, 1989, MMR vaccination and encephalitis, Br. Med. J., 299, 1219, 10.1136/bmj.299.6709.1219-b Cochi S (1989) Personal communication. Crowley, 1989, MMR vaccination and encephalitis, Br. Med. J., 299, 660, 10.1136/bmj.299.6700.660 Forsey, 1990, Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxy-nucleotide sequencing, J. Gen. Virol., 71, 987, 10.1099/0022-1317-71-4-987 Nabe-Nielsen, 1988, Unilateral deafness as a complication of MMR vaccination, Br. Med. J., 297, 489, 10.1136/bmj.297.6646.489 Rosa, 1988, Absence of antibody response to SV 40 after inoculation with killed poliovirus vaccine of mothers of offspring with neurological tumors, N. Engl. J. Med., 318, 1469, 10.1056/NEJM198806023182216 Rosa, 1988, Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine, N. Engl. J. Med., 319, 1226, 10.1056/NEJM198811033191815 Melnik, 1988, Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine, N. Engl. J. Med., 319, 1226, 10.1056/NEJM198811033191815 Esteves, 1988, Safety of oral poliomyelitis vaccine: result of a WHO enquiry, Bull. WHO, 66, 739 Kinnunen, 1989, Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign, Neurology, 39, 1034, 10.1212/WNL.39.8.1034 Uhari, 1989, Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign, Lancet, 2, 440, 10.1016/S0140-6736(89)90609-0 Harjulehto, 1989, Congenital malformations and oral poliovirus vaccination during pregnancy, Lancet, 1, 771, 10.1016/S0140-6736(89)92584-1 Lyons, 1988, Safe testing of poliovirus vaccine and the origin of HIV infection in man, S. Afr. Med. J., 74, 381 Lecatsas, 1989, Safe testing of poliovirus vaccine and the origin of HIV infection in man, S. Afr. Med. J., 76, 451 Swaddiwuthipong, 1988, A high rate of neurological complications following Semple anti-rabies vaccine, Trans. R. Soc. Trop. Med. Hyg., 82, 472, 10.1016/0035-9203(88)90167-8 Hemachudha, 1989, Enhanced antibody response to rabies virus in patients with neurologic complications following brain tissue-derived rabies vaccination, Asian Pac. J. Allergy Immunol., 7, 47 Ubol, 1990, Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera, J. Neuroimmunol., 26, 107, 10.1016/0165-5728(90)90081-W Mohan, 1989, Bladder dysfunction following beta-propriolactone inactivated anti-rabies vaccination, Indian J. Urol., 5, 78 Wali, 1988, Relapsing polyneuropathy—a case of delayed autorelapse following Semple antirabies vaccine, Neurol. India, 36, 299 Knittel, 1989, Guillain-Barré syndrome and human diploid cell rabies vaccine, Lancet, 1, 1335 Dreesen, 1989, Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization, Vaccine, 7, 400, 10.1016/0264-410X(89)90152-7 Chutivongse, 1989, Post-exposure rabies vaccination during pregnancy: experience with 21 patients, Vaccine, 7, 546, 10.1016/0264-410X(89)90280-6 Ajjan, 1989, Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells, Vaccine, 7, 125, 10.1016/0264-410X(89)90050-9 Fishbein, 1989, Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations, Vaccine, 7, 437, 10.1016/0264-410X(89)90159-X Suntharasamai, 1988, One year booster vaccination with purified vero cell rabies vaccine, Trans. R. Soc. Trop. Med. Hyg., 82, 633, 10.1016/0035-9203(88)90539-1 Perez-Schael, 1990, Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants, J. Clin. Microbiol., 28, 553, 10.1128/JCM.28.3.553-558.1990 Centers, 1989, Rubella vaccination during pregnancy—United States, 1971–1988, Morbid. Mortal. Wkly Rec., 38, 289 Allen, 1988, Is RA 27/3 rubella immunization a cause of chronic fatigue?, Med. Hypothesis, 27, 217, 10.1016/0306-9877(88)90146-6 Moss, 1988, Roles of vaccinia virus in the development of new vaccines, Vaccine, 6, 161, 10.1016/S0264-410X(88)80021-5 Watanabe, 1989, Improved recombinant LC 16 mO or LC 16 m8 vaccinia virus successfully expressing hepatitis surface antigen, Vaccine, 7, 53, 10.1016/0264-410X(89)90011-X Kappos, 1990 Schabet, 1989, Neurological complications after simultaneous immunization against tick-borne encephalitis and tetanus, Lancet, 1, 959, 10.1016/S0140-6736(89)92538-5 Magrath, 1990, Prospective vaccines for national immunization programmes Plotkin, 1989, Zoster in normal children after varicella vaccine, J. Infect. Dis., 159, 1000, 10.1093/infdis/159.5.1000 Hammerschlag, 1989, Herpes zoster in an adult recipient of live attenuated varicella vaccine, J. Infect. Dis., 160, 535, 10.1093/infdis/160.3.535 Lawrence, 1988, The risk of zoster after varicella vaccination in children with leukemia, N. Engl. J. Med., 318, 543, 10.1056/NEJM198803033180904 Lydick, 1989, Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/merck varicella vaccine, Vaccine, 7, 549, 10.1016/0264-410X(89)90281-8 Brunell, 1988, Combined vaccine against measles, mumps, rubella, and varicella, Pediatrics, 81, 779, 10.1542/peds.81.6.779 England, 1989, Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine, J. Pediatr., 114, 37, 10.1016/S0022-3476(89)80598-0 Wilde, 1989, Adverse effects of equine rabies immune globulin, Vaccine, 7, 10, 10.1016/0264-410X(89)90003-0